fluconazol cf 50 mg, capsules
centrafarm b.v. - fluconazol; - capsule, hard - fluconazole
diflucan 50 mg harde caps.
pfizer sa-nv - fluconazol 50 mg - capsule, hard - 50 mg - fluconazol 50 mg - fluconazole
diflucan 150 mg harde caps.
pfizer sa-nv - fluconazol 150 mg - capsule, hard - 150 mg - fluconazol 150 mg - fluconazole
diflucan 200 mg harde caps.
pfizer sa-nv - fluconazol 200 mg - capsule, hard - 200 mg - fluconazol 200 mg - fluconazole
diflucan 100 mg harde caps.
pfizer sa-nv - fluconazol 100 mg - capsule, hard - 100 mg - fluconazol 100 mg - fluconazole
diphantoïne 100 mg tablet
kela pharma - fenytoïnenatrium - tablet - 100 mg - fenytoïnenatrium 100 mg - phenytoin
fluconazole baxter 2 mg/ml inf. opl. i.v. flac.
baxter holding b.v. - fluconazol 200 mg/100 ml - oplossing voor infusie - 2 mg/ml - fluconazol 2 mg/ml - fluconazole
fluconazole baxter 2 mg/ml inf. opl. i.v.
baxter holding b.v. - fluconazol 200 mg/100 ml - oplossing voor infusie - 2 mg/ml - fluconazol 2 mg/ml - fluconazole
tecovirimat siga
siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirale middelen voor systemisch gebruik - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 en 5. tecovirimat siga should be used in accordance with official recommendations.
diphantoïne 100 mg tabl.
kela pharma sa-nv - fenytoïnenatrium 100 mg - tablet - phenytoin